EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Precision medicine breakthrough: Multi-omics integration elevates CAD risk prediction

Qiang Su, Qiu-Yan Li, Chen-Kai Hu, Yuan Huang, Li-Rong Mo, Wan-Zhong Huang, Di-Guang Pan

Ageing Research Reviews · 2026-11 · 122 · 103306

DOI: 10.1016/j.arr.2026.103306 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2026-11. Verfasst von Qiang Su und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, No. 85 Hedi Road, Nanning, Guangxi, 530021, China. Hauptthemen laut MEDLINE: Coronary Artery Disease, Precision Medicine, Proteomics, Genomics. Die Arbeit nennt 31 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Guangxi Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Coronary artery disease (CAD) remains the leading cause of global mortality. Multi-omics integration offers unprecedented opportunities for precision risk stratification beyond conventional approaches. However, comprehensive integration of genomic, proteomic, and metabolomic data for CAD prediction remains underexplored. METHODS: We integrated genomic (n = 442,574), proteomic (n = 54,219 with 1472 proteins), and metabolomic (n = 121,249 with 249 metabolites) data from UK Biobank. Multi-omics integration employed similarity network fusion combined with elastic net regularization in the 23,776 participants with complete multi-omics data, with a late integration (stacking) strategy applied for prediction modeling across the full cohort. Internal validation encompassed temporal split (2006-2008 vs. 2009-2010), geographical split (England vs. Scotland/Wales), 10-fold cross-validation, and bootstrap resampling (1000 iterations). RESULTS: Among 442,574 participants (34,241 CAD cases, 7.74%), we identified 241 independent genomic loci and integrated 1472 proteins with 249 metabolites. Network analysis revealed four major biological modules: vascular dysfunction (37.8% variance), lipid metabolism (25.4%), inflammatory response (19.2%), and cardiac remodeling (13.6%). The integrated multi-omics model achieved superior discrimination (C-statistic: 0.798, 95% CI: 0.793-0.803) compared to clinical factors alone (0.741) and genomics-only approaches (0.704, P < 0.001), with net reclassification improvement of 10.34% (95% CI: 8.92-11.77%). Temporal validation demonstrated robust transportability (C-statistic: 0.791) with consistent calibration (Hosmer-Lemeshow χ²=8.73, P = 0.366). Individuals in the highest risk quintile exhibited 4.52-fold increased CAD odds (95% CI: 4.28-4.78) with 10-year incidence of 11.24% compared to 2.51% in the lowest quintile. Drug target analysis identified 8 proteins targeted by approved cardiovascular drugs and 5 additional targets in Phase II/III clinical trials, supporting translational potential. CONCLUSIONS: Multi-omics integration substantially enhances CAD risk prediction with robust internal validation, enabling targeted precision medicine strategies through successful intermediate-risk reclassification. These findings establish a framework for clinical translation of multi-omics risk assessment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Coronary Artery DiseasePrecision MedicineProteomicsGenomicsMetabolomicsHumansMultiomicsRisk AssessmentRisk Factors

Stichwörter der Autor:innen

Coronary artery diseaseInternal validationMulti-omics integrationPolygenic risk scorePrecision medicineRisk stratificationUK Biobank

Autor:innen und Institutionen

  • Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, No. 85 Hedi Road, Nanning, Guangxi, 530021, China.
  • Department of Cardiology, Guilin People's Hospital, No.12 Wenming Road, Guilin, Guangxi, 541002, China.
  • Department of Cardiology, the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, No. 1 Minde Road, Nanchang, Jiangxi, 330006, China.
  • Department of Cardiology, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, No. 85 Hedi Road, Nanning, Guangxi, 530021, China. Electronic address: drwanzhong@163.com.
  • Department of Cardiology, Guilin People's Hospital, No.12 Wenming Road, Guilin, Guangxi, 541002, China. Electronic address: diguangpan1028@163.com.

Förderung

  • National Natural Science Foundation of China
  • Guangxi Key Research and Development Program

Zitieren

APA

Su, Q., Li, Q. Y., Hu, C. K., Huang, Y., Mo, L. R., Huang, W. Z., & Pan, D. G. (2026). Precision medicine breakthrough: Multi-omics integration elevates CAD risk prediction. Ageing Research Reviews, 122, 103306. https://doi.org/10.1016/j.arr.2026.103306

Vancouver

Su Q, Li QY, Hu CK, Huang Y, Mo LR, Huang WZ, et al. Precision medicine breakthrough: Multi-omics integration elevates CAD risk prediction. Ageing Research Reviews. 2026;122:103306. doi:10.1016/j.arr.2026.103306

BibTeX
@article{Su2026,
  author = {Su, Qiang and Li, Qiu-Yan and Hu, Chen-Kai and Huang, Yuan and Mo, Li-Rong and Huang, Wan-Zhong and Pan, Di-Guang},
  title = {Precision medicine breakthrough: Multi-omics integration elevates CAD risk prediction},
  journal = {Ageing Research Reviews},
  year = {2026},
  volume = {122},
  pages = {103306},
  doi = {10.1016/j.arr.2026.103306}
}
Kostenlos starten →